An independent review has been conducted to evaluate the efficacy of PainChek to improve the diagnosis and management of pain, quality of life, and/or health outcomes in people living with dementia in residential aged care. The findings were highly positive, with the national trial resulting in significant progress being made within the sector... Lets see whats in the pipeline with Government trial ending on the 31st May. And what recommendation is put Forward
PCK Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held
